Short Interest in Xenetic Biosciences, Inc. (NASDAQ:XBIOW) Declines By 50.0%

Xenetic Biosciences, Inc. (NASDAQ:XBIOW) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 200 shares, a drop of 50.0% from the March 31st total of 400 shares. Based on an average daily trading volume, of 300 shares, the days-to-cover ratio is currently 0.7 days.

Xenetic Biosciences Price Performance

Shares of XBIOW opened at $7.46 on Friday. The stock’s fifty day simple moving average is $11.57 and its 200 day simple moving average is $8.09. Xenetic Biosciences has a twelve month low of $0.70 and a twelve month high of $23.16.

About Xenetic Biosciences

Xenetic Biosciences, Inc, a biopharmaceutical company, focuses on advancing immune-oncology technologies for hard to treat cancers. The company's proprietary DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments that targets pancreatic cancer comprising pancreatic ductal adenocarcinoma, colorectal carcinoma, and other gastrointestinal cancer.